SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001213900-18-006810
Filing Date
2018-05-24
Accepted
2018-05-24 08:00:18
Documents
1
Period of Report
2018-05-22

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT f4052218schreiber_immudyne.html 4  
1 OWNERSHIP DOCUMENT f4052218schreiber_immudyne.xml 4 8521
  Complete submission text file 0001213900-18-006810.txt   9947
Mailing Address 1460 BROADWAY NEW YORK NY 10036
Business Address 1460 BROADWAY NEW YORK NY 10036 914-244-1777
Immudyne, Inc. (Issuer) CIK: 0000948320 (see all company filings)

IRS No.: 760238453 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2833 Medicinal Chemicals & Botanical Products

Mailing Address 53 CALLE PALMERAS SUITE 802 SAN JUAN PR 00901
Business Address
Schreiber Justin (Reporting) CIK: 0001720512 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-55857 | Film No.: 18856663